These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10825993)

  • 21. Fusarium merismoides Corda NR 6356, the source of the protein kinase C inhibitor, azepinostatin. Taxonomy, yield improvement, fermentation and biological activity.
    Ohshima S; Yanagisawa M; Katoh A; Fujii T; Sano T; Matsukuma S; Furumai T; Fujiu M; Watanabe K; Yokose K
    J Antibiot (Tokyo); 1994 Jun; 47(6):639-47. PubMed ID: 8040068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development.
    Goekjian PG; Jirousek MR
    Curr Med Chem; 1999 Sep; 6(9):877-903. PubMed ID: 10495357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
    Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS
    Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A square-planar organoiron(III) compound with a spin-admixed state.
    Alonso PJ; Arauzo AB; Forniés J; García-Monforte MA; Martín A; Martínez JI; Menjón B; Rillo C; Sáiz-Garitaonandia JJ
    Angew Chem Int Ed Engl; 2006 Oct; 45(40):6707-11. PubMed ID: 16977656
    [No Abstract]   [Full Text] [Related]  

  • 25. Stereochemical requirements of oxidative cyclizations in extended iterative organoiron-mediated routes to alkaloids.
    Stephenson GR; Roe C; Anson CE
    J Org Chem; 2012 Nov; 77(21):9684-92. PubMed ID: 23066933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of polyhydroxy benzophenone as mushroom tyrosinase inhibitors.
    Wu J; Hu X; Ma L
    J Enzyme Inhib Med Chem; 2011 Jun; 26(3):449-52. PubMed ID: 20939763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A facile synthetic route to diazepinone derivatives via ring closing metathesis and its application for human cytidine deaminase inhibitors.
    Kim M; Gajulapati K; Kim C; Jung HY; Goo J; Lee K; Kaur N; Kang HJ; Chung SJ; Choi Y
    Chem Commun (Camb); 2012 Dec; 48(93):11443-5. PubMed ID: 23086289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tenellones A and B from a Diaporthe sp.: two highly substituted benzophenone inhibitors of parasite cGMP-dependent protein kinase activity.
    Zhang C; Ondeyka JG; Herath KB; Guan Z; Collado J; Platas G; Pelaez F; Leavitt PS; Gurnett A; Nare B; Liberator P; Singh SB
    J Nat Prod; 2005 Apr; 68(4):611-3. PubMed ID: 15844962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studying protein-peptide interactions using benzophenone units: a case study of protein kinase B/Akt and its inhibitor PTR6154.
    Tal-Gan Y; Naveh S; Klein S; Moshel O; Levitzki A; Gilon C
    Anal Biochem; 2012 Feb; 421(2):750-4. PubMed ID: 22197420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis.
    Gould C; Wong CF
    Pharmacol Ther; 2002; 93(2-3):169-78. PubMed ID: 12191609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formal total synthesis of (-)-balanol: concise approach to the hexahydroazepine segment based on RCM.
    Fürstner A; Thiel OR
    J Org Chem; 2000 Mar; 65(6):1738-42. PubMed ID: 10750493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel transition state analog inhibitor of guanase based on azepinomycin ring structure: Synthesis and biochemical assessment of enzyme inhibition.
    Chakraborty S; Shah NH; Fishbein JC; Hosmane RS
    Bioorg Med Chem Lett; 2011 Jan; 21(2):756-9. PubMed ID: 21183343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achiral benzophenone ligand-rhodium complex with chiral diamine activator for high enantiocontrol in asymmetric transfer hydrogenation.
    Mikami K; Wakabayashi K; Yusa Y; Aikawa K
    Chem Commun (Camb); 2006 Jun; (22):2365-7. PubMed ID: 16733581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An iron carbonyl approach to the influenza neuraminidase inhibitor oseltamivir.
    Bromfield KM; Gradén H; Hagberg DP; Olsson T; Kann N
    Chem Commun (Camb); 2007 Aug; (30):3183-5. PubMed ID: 17653382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular docking of balanol to dynamics snapshots of protein kinase A.
    Wong CF; Kua J; Zhang Y; Straatsma TP; McCammon JA
    Proteins; 2005 Dec; 61(4):850-8. PubMed ID: 16245317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virtual kinetics: using statistical experimental design for rapid analysis of enzyme inhibitor mechanisms.
    Bronson DD; Daniels DM; Dixon JT; Redick CC; Haaland PD
    Biochem Pharmacol; 1995 Sep; 50(6):823-31. PubMed ID: 7575644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthase.
    Moormann AE; Metz S; Toth MV; Moore WM; Jerome G; Kornmeier C; Manning P; Hansen DW; Pitzele BS; Webber RK
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2651-3. PubMed ID: 11551770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iridium-monodentate phosphoramidite-catalyzed asymmetric hydrogenation of substituted benzophenone N-H imines.
    Hou G; Tao R; Sun Y; Zhang X; Gosselin F
    J Am Chem Soc; 2010 Feb; 132(7):2124-5. PubMed ID: 20104899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of telomerase activity by fungus metabolites, CRM646-A and thielavin B.
    Togashi K; Ko HR; Ahn JS; Osada H
    Biosci Biotechnol Biochem; 2001 Mar; 65(3):651-3. PubMed ID: 11330682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.